CTLA4 and neoplasm: From an “oncological” point of view, the most important feature of CTLA-4 is its engagement in evading immune surveillance by cancer cells, since cancer cells may employ mechanisms leading to upregulation of CTLA-4 and as consequence repression of immune response toward tumor cells (18).